Intra-Cellular Therapies Inc. (ITCI): Price and Financial Metrics

Intra-Cellular Therapies Inc. (ITCI)

Today's Latest Price: $21.59 USD

0.22 (1.03%)

Updated Jun 5 4:00pm

Add ITCI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

ITCI Stock Summary

  • With a price/sales ratio of 1,253.98, Intra-Cellular Therapies Inc has a higher such ratio than 99.59% of stocks in our set.
  • As for revenue growth, note that ITCI's revenue has grown 1,787.54% over the past 12 months; that beats the revenue growth of 99.54% of US companies in our set.
  • In terms of volatility of its share price, ITCI is more volatile than 91.68% of stocks we're observing.
  • Stocks that are quantitatively similar to ITCI, based on their financial statements, market capitalization, and price volatility, are TOCA, MRSN, CRMD, CBMG, and SCYX.
  • ITCI's SEC filings can be seen here. And to visit Intra-Cellular Therapies Inc's official web site, go to
ITCI Daily Price Range
ITCI 52-Week Price Range

ITCI Stock Price Chart More Charts

ITCI Price/Volume Stats

Current price $21.59 52-week high $43.56
Prev. close $21.37 52-week low $6.75
Day low $21.34 Volume 913,465
Day high $22.26 Avg. volume 1,150,660
50-day MA $18.68 Dividend yield N/A
200-day MA $16.18 Market Cap 1.43B

Intra-Cellular Therapies Inc. (ITCI) Company Bio

Intra-Cellular Therapies is developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinson's and Alzheimer's disease. The company was founded in 2002 and is based in New York, New York.

ITCI Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ITCI Latest Social Stream

Loading social stream, please wait...

View Full ITCI Social Stream

Latest ITCI News From Around the Web

Below are the latest news stories about Intra-Cellular Therapies Inc that investors may wish to consider to help them evaluate ITCI as an investment opportunity.

Implied Volatility Surging for Intra-Cellular Therapies (ITCI) Stock Options

Investors need to pay close attention to Intra-Cellular Therapies (ITCI) stock based on the movements in the options market lately.

Yahoo | June 4, 2020

Intra-Cellular Therapies' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Intra-Cellular Therapies

Yahoo | May 26, 2020

Intra-Cellular Therapies to Present at the 2020 RBC Capital Markets Global Healthcare Conference

NEW YORK, May 14, 2020 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central.

Yahoo | May 14, 2020

Intra-Cellular Therapies to Host Virtual Annual Meeting of Stockholders

Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) virtually due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of meeting participants. Stockholders will not be able to attend the Annual Meeting in person, however, stockholders of record and registered beneficial owners as of the close of business on April 6, 2020, will be able to vote and ask questions during the meeting through the online platform. Stockholders can attend the meeting by accessing and entering the 15-digi...

Yahoo | May 13, 2020

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

The investors in Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) will be rubbing their hands together with glee today...

Yahoo | May 9, 2020

Read More 'ITCI' Stories Here

ITCI Price Returns

1-mo 17.98%
3-mo 2.27%
6-mo 86.93%
1-year 90.39%
3-year 122.12%
5-year -20.63%
YTD -37.07%
2019 201.23%
2018 -21.34%
2017 -4.04%
2016 -71.95%
2015 204.76%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8092 seconds.